By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GE Healthcare announced today that it has inked a deal to acquire molecular diagnostics and imaging firm Clarient for around $580 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.